Yabao Pharmaceutical Group Co. Ltd. provided earnings guidance for the first three quarters of 2018. According to preliminary statistics of its financial department, the company predicts that the net profit belonging to shareholders of the listed company will increase by RMB 59,304,800 and RMB 74,131,100 in the first three quarters of 2018, with an increase of between 40% and 50% compared with the same period of the year before and the net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 53,885,200 and RMB 68,711,400 with an increase of between 37% and 48% compared with the same period of the year before.